Cspc Zhongnuo Pharmaceutical (shijiazhuang) Co., Ltd.

This study aims to see if a new, generic version of a long-acting schizophrenia injection works the same in the body as the existing brand-name version. It will involve 260 adults in China with stable schizophrenia. Researchers will measure drug levels in the blood and track side…

This is the first study in people to test the safety and effects of a new injection called SYH2070. It will be given to 48 healthy volunteers who have high levels of certain fats in their blood. The main goal is to see how safe it is and how the body processes it, while also chec…